| Dr Charles R Varcoe Od Pc | |
|
209 Nile Kinnick Dr S, Adel, IA 50003-1728 | |
| (515) 993-4753 | |
| (515) 993-4754 |
| Full Name | Dr Charles R Varcoe Od Pc |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 209 Nile Kinnick Dr S, Adel, Iowa |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386830487 | NPI | - | NPPES |
| 13948 | Other | IA | MEDICARE ID-PIN |
| 0139485 | Medicaid | IA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 01604 (Iowa) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Charles R Varcoe Od Pc 209 Nile Kinnick Dr S, Adel, IA 50003-1728 Ph: (515) 993-4753 | Dr Charles R Varcoe Od Pc 209 Nile Kinnick Dr S, Adel, IA 50003-1728 Ph: (515) 993-4753 |
News Archive
The U.S. Food and Drug Administration (FDA) has issued a warning in connection with the drug Provigil because of dangerous side effects.
According to an announcement from the Food and Drug Administration (FDA) on Monday, it has approved the new flu vaccine for the season beginning this year. Each year the FDA works with other federal agencies and global health experts to design a vaccine to protect against the three viral strains most likely to cause the flu.
Facing challenges in their home state, top executives of Boston-based Partners HealthCare System told a national audience of investors Monday that they will create a bold "new medical model" by integrating hospitals and their medical services with insurance products and by drawing patients from across the country. Speaking at the J.P. Morgan Healthcare Conference, Partners' chief executive, Gary L. Gottlieb, said his organization, which owns Harvard-affiliated Massachusetts General and Brigham and Women's hospitals in Boston, plans to improve medical care and lower costs by further expanding its network of community hospitals and primary care physicians in Eastern Massachusetts (Weisman, 1/14).
GlycoMimetics, Inc., a clinical-stage biotechnology company developing a new class of glycobiology-based therapies for a broad range of indications, today announced that two oral presentations and two abstracts were delivered at the 52nd Annual Meeting of the American Society of Hematology in Orlando, Florida. The presentations and abstracts highlighted clinical and preclinical progress with GlycoMimetics's lead compound GMI-1070, now in Phase 2 clinical trials in sickle cell crisis.
› Verified 3 days ago
Adel Vision Clinic Optometrist Medicare: Medicare Enrolled Practice Location: 813 Main St, Adel, IA 50003 Phone: 515-207-7400 | |
Dr. Marcia Jean Holstad, OD Optometrist Medicare: Medicare Enrolled Practice Location: 813 Main St, Adel, IA 50003 Phone: 515-207-7400 Fax: 515-478-1076 | |
Dr. Charles R Varcoe, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 209 Nile Kinnick Dr S, Adel, IA 50003 Phone: 515-993-4753 Fax: 515-993-4754 |